$CLRC
ClimateRock Stock $clrc

$clrc Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000121390024023601 Filed on March 18, 2024

Income Statement

Concept	2023 Q4	2023	2022
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$122.9K	$122.9K
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses	$474.0K	$1.651M	$1.768M
YoY Change	-35.4%	-6.61%	37281.61%
Operating Profit		-$1.651M	-$1.768M
YoY Change		-6.61%
Interest Expense	$372.3K	$2.135M	$1.092M
YoY Change	-42.9%	95.43%
% of Operating Profit
Other Income/Expense, Net		$2.135M	$1.092M
YoY Change		95.43%
Pretax Income	-$101.8K	$483.4K	-$675.9K
YoY Change	24.36%	-171.53%	14189.01%
Income Tax
% Of Pretax Income
Net Earnings	-$101.8K	$483.4K	-$675.9K
YoY Change	24.36%	-171.53%	14189.09%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share	-$0.02	$0.08	-$0.07
COMMON SHARES
Basic Shares Outstanding
Diluted Shares Outstanding

Balance Sheet

Concept	2023 Q4	2023	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$28.57M	$28.57M	$81.45M
YoY Change	-64.93%	-64.93%
Cash & Equivalents	$57.29K	$28.51M	$81.04M
Short-Term Investments
Other Short-Term Assets	$410.00	$410.00	$106.5K
YoY Change	-99.62%	-99.62%	27.84%
Inventory
Prepaid Expenses	$412.00
Receivables
Other Receivables
Total Short-Term Assets	$57.70K	$28.57M	$81.56M
YoY Change	-99.93%	-64.97%	97761.0%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments	$28.51M	$28.51M
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$28.51M	$0.00	$0.00
YoY Change
TOTAL ASSETS
Total Short-Term Assets	$57.70K	$28.57M	$81.56M
Total Long-Term Assets	$28.51M	$0.00	$0.00
Total Assets	$28.57M	$28.57M	$81.56M
YoY Change	-64.97%	-64.97%	97761.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$184.9K	$184.9K
YoY Change
Accrued Expenses	$959.7K	$959.7K	$3.368M
YoY Change	-4.57%	-71.51%
Deferred Revenue
YoY Change
Short-Term Debt	$600.0K	$600.0K	$480.0K
YoY Change	25.0%	25.0%	661.06%
Long-Term Debt Due	$1.482M	$1.482M
YoY Change
Total Short-Term Liabilities	$3.226M	$3.226M	$3.848M
YoY Change	-16.16%	-16.16%	6001.51%
LONG-TERM LIABILITIES
Long-Term Debt	$50.00K	$50.00K	$0.00
YoY Change
Other Long-Term Liabilities	$2.363M	$2.363M
YoY Change
Total Long-Term Liabilities	$2.413M	$2.413M	$0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$3.226M	$3.226M	$3.848M
Total Long-Term Liabilities	$2.413M	$2.413M	$0.00
Total Liabilities	$5.639M	$5.639M	$3.848M
YoY Change	46.53%	46.53%	6001.51%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.581M
YoY Change	67.59%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$5.581M	$22.93M	$77.71M
YoY Change
Total Liabilities & Shareholders Equity	$28.57M	$28.57M	$81.56M
YoY Change	-64.97%	-64.97%	97761.0%

Cashflow Statement

Concept	2023 Q4	2023	2022
OPERATING ACTIVITIES
Net Income	-$101.8K	$483.4K	-$675.9K
YoY Change	24.36%	-171.53%	14189.09%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities	-$433.2K	-$1.406M	-$884.5K
YoY Change	71.77%	58.95%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$225.0K	$54.67M	-$79.93M
YoY Change		-168.39%
Cash From Investing Activities	-$225.0K	$54.67M	-$79.93M
YoY Change		-168.39%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$55.27M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	635.6K	-$53.61M	$81.23M
YoY Change	111.88%	-166.0%
NET CHANGE
Cash From Operating Activities	-433.2K	-$1.406M	-$884.5K
Cash From Investing Activities	-225.0K	$54.67M	-$79.93M
Cash From Financing Activities	635.6K	-$53.61M	$81.23M
Net Change In Cash	-22.53K	-$354.4K	$411.7K
YoY Change	-147.11%	-186.08%
FREE CASH FLOW
Cash From Operating Activities	-$433.2K	-$1.406M	-$884.5K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-41363
CY2023	dei	Entity Registrant Name EntityRegistrantName	CLIMATEROCK
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	E9
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	25 Bedford Square
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	London
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	WC1B 3HH
CY2023	dei	Entity Address Country EntityAddressCountry	GB
CY2023	dei	City Area Code CityAreaCode	+44
CY2023	dei	Local Phone Number LocalPhoneNumber	730 847 5096
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	true
CY2023	dei	Document Fin Stmt Restatement Recovery Analysis Flag DocumentFinStmtRestatementRecoveryAnalysisFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	true
CY2023Q2	dei	Entity Public Float EntityPublicFloat	27523834	usd
CY2023Q4	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q4	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2023Q4	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023	dei	Auditor Firm AuditorFirmId	1195
CY2023	dei	Auditor Name AuditorName	UHY LLP
CY2023	dei	Auditor Location AuditorLocation	New York
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57290	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	411711	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	412	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	106542	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	57702	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	518253	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	28508214	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	81039102	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	28508214	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	81039102	usd
CY2023Q4	us-gaap	Assets Assets	28565916	usd
CY2022Q4	us-gaap	Assets Assets	81557355	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	959720	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	935421	usd
CY2023Q4	clcr	Notes Payable Current Administrative Service NotesPayableCurrentAdministrativeService	184941	usd
CY2022Q4	clcr	Notes Payable Current Administrative Service NotesPayableCurrentAdministrativeService	70299	usd
CY2023Q4	us-gaap	Loans Payable Current LoansPayableCurrent	1481524	usd
CY2022Q4	us-gaap	Loans Payable Current LoansPayableCurrent	480000	usd
CY2023Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	600000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	3226185	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1485720	usd
CY2023Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable	50000	usd
CY2023Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2362500	usd
CY2022Q4	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2362500	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2412500	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2362500	usd
CY2023Q4	us-gaap	Liabilities Liabilities	5638685	usd
CY2022Q4	us-gaap	Liabilities Liabilities	3848220	usd
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	28508214	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	81039102	usd
CY2023Q4	clcr	Total Commitment And Contingencies TotalCommitmentAndContingencies	28508214	usd
CY2022Q4	clcr	Total Commitment And Contingencies TotalCommitmentAndContingencies	81039102	usd
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-5581192	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3330176	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5580983	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3329967	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28565916	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	81557355	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1528302	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1666924	usd
CY2023	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	122904	usd
CY2022	us-gaap	Administrative Fees Expense AdministrativeFeesExpense	101223	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-1651206	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-1768147	usd
CY2023	us-gaap	Investment Income Interest InvestmentIncomeInterest	190	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2134446	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1107852	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-15579	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	2134636	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1092273	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	483430	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-675874	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20270	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures	187500	usd
CY2022	clcr	Sale Of Unit SaleOfUnit	7875000	shares
CY2022	clcr	Sale Of Per Unit SaleOfPerUnit	10
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	73656058	usd
CY2022	clcr	Issuance Of Underwriter Units IssuanceOfUnderwriterUnits	118125	shares
CY2022	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	946181	usd
CY2022	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	3762500	shares
CY2022	us-gaap	Adjustments To Additional Paid In Capital Warrant Issued AdjustmentsToAdditionalPaidInCapitalWarrantIssued	3762500	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-81039102	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-675874	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-3329967	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	-2734446	usd
CY2023	clcr	Conversion Of Shares ConversionOfShares	1968749	shares
CY2023	clcr	Conversion Price Par Value ConversionPriceParValue	0.0001
CY2023	us-gaap	Net Income Loss NetIncomeLoss	483430	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-5580983	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	483430	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-675874	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2134446	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1107852	usd
CY2022	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty	15579	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	24299	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	919842	usd
CY2023	clcr	Increase Decrease In Administrative Service Fee Payable Related Party IncreaseDecreaseInAdministrativeServiceFeePayableRelatedParty	114642	usd
CY2022	clcr	Increase Decrease In Administrative Service Fee Payable Related Party IncreaseDecreaseInAdministrativeServiceFeePayableRelatedParty	70299	usd
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-106130	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	106542	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1405945	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-884548	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	55265334	usd
CY2023	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	600000	usd
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	79931250	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	54665334	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-79931250	usd
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1060921	usd
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	485150	usd
CY2023	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	600000	usd
CY2023	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	9397	usd
CY2022	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	217641	usd
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	55265334	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	78750000	usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	1552500	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	3762500	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-53613810	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	81227509	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-354421	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	411711	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411711	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	57290	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	411711	usd
CY2022	clcr	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty	149418	usd
CY2022	clcr	Deferred Underwriting Commission Charged To Additional Paid In Capital DeferredUnderwritingCommissionChargedToAdditionalPaidInCapital	2362500	usd
CY2022	clcr	Allocation Of Offering Costs To Class A Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToClassAOrdinarySharesSubjectToRedemption	304011	usd
CY2022	clcr	Issuance Of Representative Shares IssuanceOfRepresentativeShares	946181	usd
CY2022	clcr	Initial Value Of Public Shares Subject To Possible Redemptionin Shares InitialValueOfPublicSharesSubjectToPossibleRedemptioninShares	71851500	usd
CY2022	clcr	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares	-4647702	usd
CY2023	clcr	Remeasurement Adjustment On Public Shares Subject To Possible Redemption RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption	2734446	usd
CY2022	clcr	Remeasurement Adjustment On Public Shares Subject To Possible Redemption RemeasurementAdjustmentOnPublicSharesSubjectToPossibleRedemption	13835304	usd
CY2023	us-gaap	Payments For Underwriting Expense PaymentsForUnderwritingExpense	1181250	usd
CY2023	us-gaap	Payments For Commissions PaymentsForCommissions	2362500	usd
CY2023	us-gaap	Other Cost And Expense Operating OtherCostAndExpenseOperating	604011	usd
CY2023	us-gaap	Sale Of Stock Consideration Received On Transaction SaleOfStockConsiderationReceivedOnTransaction	79931250	usd
CY2023	us-gaap	Cash Acquired From Acquisition CashAcquiredFromAcquisition	57290	usd
CY2023Q4	clcr	Assets Held In Trust Account AssetsHeldInTrustAccount	0.80	pure
CY2023Q4	clcr	Interest Earned On The Funds Held In The Trust Account InterestEarnedOnTheFundsHeldInTheTrustAccount	11.06
CY2023Q4	us-gaap	Deposits Deposits	787500	usd
CY2023Q4	clcr	Deposits Per Share DepositsPerShare	0.1
CY2023Q2	clcr	Sponsor Loan SponsorLoan	75000	usd
CY2023Q4	us-gaap	Cash Cash	57290	usd
CY2023Q4	clcr	Working Capital Deficit WorkingCapitalDeficit	3168483	usd
CY2023	us-gaap	Fiscal Period FiscalPeriod	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Prior period reclassifications</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">To conform with the current period presentation, management has reclassified a portion of the amount previously presented within “Accrued liabilities” on the Balance Sheet as of December 31, 2022, “Formation and operating costs” on the Statement of Operations for the year ended December 31, 2022, and “Accrued liabilities, excluding unrealized foreign exchange loss” on the Statement of Cash Flows for the year ended December 31, 2022 as “Administrative service fee payable - related party”, “Administrative service fees - related party”, and “Administrative service fee payable - related party”, respectively.</p>
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	57290	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	411711	usd
CY2023Q4	clcr	Transactions Payable TransactionsPayable	1600000	usd
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	28508214	usd
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	81039102	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2134446	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1107852	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Accordingly, the actual results could differ significantly from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.25in"> </p>
CY2023	us-gaap	Net Income Loss NetIncomeLoss	483430	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-675874	usd
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	12727452	usd
CY2023	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-483430	usd
CY2022	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	13403326	usd
CY2023	clcr	Monthly Extension Fees MonthlyExtensionFees	600000	usd
CY2023	us-gaap	Investment Income Dividend InvestmentIncomeDividend	2134446	usd
CY2022	us-gaap	Investment Income Dividend InvestmentIncomeDividend	1107852	usd
CY2023	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-2251016	usd
CY2022	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-14511178	usd
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	11.5
CY2022Q2	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	375000	shares
CY2022Q2	clcr	Founder Shares Were No Longer Subject To Forfeiture FounderSharesWereNoLongerSubjectToForfeiture	93750	shares
CY2022Q2	clcr	Number Of Shares Subject To Forfeiture NumberOfSharesSubjectToForfeiture	187500	shares
CY2021Q4	clcr	Due To Affiliate DueToAffiliate	63073	usd
CY2022Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	180000	usd
CY2022Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	300000	usd
CY2023Q1	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	50000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	150000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	125000	usd
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	125000	usd
CY2023Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	100000	usd
CY2023Q4	us-gaap	Related Party Deposit Liabilities RelatedPartyDepositLiabilities	653619	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	335000	usd
CY2023Q4	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	22302	usd
CY2023Q4	clcr	Interest Rate Percentage InterestRatePercentage	0.05	pure
CY2023Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	900000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	75000	usd
CY2023Q2	clcr	Interest Rate Percentage InterestRatePercentage	0.05	pure
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1
CY2023Q2	us-gaap	Product Liability Contingency Loss Exposure Not Accrued Best Estimate ProductLiabilityContingencyLossExposureNotAccruedBestEstimate	600000	usd
CY2023Q4	clcr	Notes Payable Current Administrative Service NotesPayableCurrentAdministrativeService	184941	usd
CY2022Q3	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	500000	usd
CY2022Q3	clcr	Purchase Price PurchasePrice	400000000	usd
CY2022Q3	clcr	Total Remuneration Transaction Price TotalRemunerationTransactionPrice	400000001	usd
CY2022Q3	clcr	Transactions Purchase Price TransactionsPurchasePrice	1000000	usd
CY2022Q4	us-gaap	Payment For Administrative Fees PaymentForAdministrativeFees	250000	usd
CY2022Q4	us-gaap	Additional Collateral Aggregate Fair Value AdditionalCollateralAggregateFairValue	400000000	usd
CY2023	clcr	Cash Fee Payable Percentage CashFeePayablePercentage	0.02	pure
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	375000	shares
CY2023	us-gaap	Other Underwriting Expense OtherUnderwritingExpense	0.45	usd
CY2023	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	125000	usd
CY2023	clcr	Outstanding Billed Amount For Services Provided OutstandingBilledAmountForServicesProvided	892784	usd
CY2022	clcr	Outstanding Billed Amount For Services Provided OutstandingBilledAmountForServicesProvided	634055	usd
CY2023	clcr	Outstanding Balance Amount OutstandingBalanceAmount	446392	usd
CY2022	clcr	Outstanding Balance Amount OutstandingBalanceAmount	317027	usd
CY2023	clcr	Outstanding Balance Percentage OutstandingBalancePercentage	0.50	pure
CY2023Q1	clcr	Gross Proceeds Received Percentage GrossProceedsReceivedPercentage	0.01	pure
CY2022Q3	us-gaap	Principal Transactions Revenue PrincipalTransactionsRevenue	50000000	usd
CY2022Q3	us-gaap	Adjustments To Additional Paid In Capital Stock Split AdjustmentsToAdditionalPaidInCapitalStockSplit	150000	usd
CY2022Q3	us-gaap	Payments For Fees PaymentsForFees	40000000	usd
CY2022Q3	clcr	Transaction Success Fee TransactionSuccessFee	500000	usd
CY2022Q3	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	15000	usd
CY2022Q3	us-gaap	Increase Decrease Due From Affiliates IncreaseDecreaseDueFromAffiliates	20000	usd
CY2022Q3	clcr	Aggregate Transaction Value AggregateTransactionValue	400000000	usd
CY2023Q4	clcr	Transactions Behalf Payable TransactionsBehalfPayable	1600000	usd
CY2023	clcr	Aggregate Transaction Value AggregateTransactionValue	300000000	usd
CY2023	clcr	Transaction Purchase Price TransactionPurchasePrice	0.0085	pure
CY2022Q3	clcr	Retainer Fees RetainerFees	40000	usd
CY2023Q4	us-gaap	Fair Value Option Aggregate Differences Long Term Debt Instruments FairValueOptionAggregateDifferencesLongTermDebtInstruments	300000000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent	0.004	pure
CY2023	clcr	Transaction Success Fee TransactionSuccessFee	1000000	eur
CY2023	us-gaap	Other Payments To Acquire Businesses OtherPaymentsToAcquireBusinesses	650000000	usd
CY2023	clcr	Shares Based On The Achievement Amount SharesBasedOnTheAchievementAmount	150000000	usd
CY2023	us-gaap	Revenue Recognition Milestone Method Revenue Recognized RevenueRecognitionMilestoneMethodRevenueRecognized	52000000	usd
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023	clcr	Redemption Price Per Warrant RedemptionPricePerWarrant	0.01
CY2023	clcr	Number Of Days For Written Notice Of Redemption NumberOfDaysForWrittenNoticeOfRedemption	P30Y
CY2023	clcr	Minimum Threshold Price Of Common Stock Specified To Send Notice Of Redemption To The Warrant Holders MinimumThresholdPriceOfCommonStockSpecifiedToSendNoticeOfRedemptionToTheWarrantHolders	18
CY2023	clcr	Common Stock Threshold Trading Days CommonStockThresholdTradingDays	20	pure
CY2023	clcr	Common Stock Threshold Consecutive Trading Days CommonStockThresholdConsecutiveTradingDays	30	pure
CY2023	clcr	Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPrice	9.2
CY2023Q4	clcr	Price Threshold Of Newly Issued Stock To Cause Adjustment Of Exercise Warrant Price Percentage Of Equity Proceeds From Issuance PriceThresholdOfNewlyIssuedStockToCauseAdjustmentOfExerciseWarrantPricePercentageOfEquityProceedsFromIssuance	0.60	pure
CY2023	clcr	Percentage Of Warrant Exercise Price Adjusted To Price Received In New Issuance PercentageOfWarrantExercisePriceAdjustedToPriceReceivedInNewIssuance	1.15	pure
CY2023Q4	clcr	Class Of Warrant Or Right Target Share Price Of Warrants Or Rights For Redemption ClassOfWarrantOrRightTargetSharePriceOfWarrantsOrRightsForRedemption	18
CY2022Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent		usd
CY2022Q4	us-gaap	Long Term Loans Payable LongTermLoansPayable		usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized		usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited		usd
CY2023	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
CY2023	us-gaap	Costs And Expenses Related Party CostsAndExpensesRelatedParty		usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities		usd
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock		usd
CY2023	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2023	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement		usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
CY2023	clcr	Deferred Offering Costs Paid By Related Party DeferredOfferingCostsPaidByRelatedParty		usd
CY2023	clcr	Deferred Underwriting Commission Charged To Additional Paid In Capital DeferredUnderwritingCommissionChargedToAdditionalPaidInCapital		usd
CY2023	clcr	Allocation Of Offering Costs To Class A Ordinary Shares Subject To Redemption AllocationOfOfferingCostsToClassAOrdinarySharesSubjectToRedemption		usd
CY2023	clcr	Issuance Of Representative Shares IssuanceOfRepresentativeShares		usd
CY2023	clcr	Initial Value Of Public Shares Subject To Possible Redemptionin Shares InitialValueOfPublicSharesSubjectToPossibleRedemptioninShares		usd
CY2023	clcr	Reclassification Of Offering Costs Related To Public Shares ReclassificationOfOfferingCostsRelatedToPublicShares		usd
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue		usd
CY2022	clcr	Monthly Extension Fees MonthlyExtensionFees		usd
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001903392

Files In Submission

Name	View Source	Status
0001213900-24-023601-index-headers.html	Edgar Link	pending
0001213900-24-023601-index.html	Edgar Link	pending
0001213900-24-023601.txt	Edgar Link	pending
R8.htm	Edgar Link	pending
0001213900-24-023601-xbrl.zip	Edgar Link	pending
clcr-20231231.xsd	Edgar Link	pending
ea0201612-10k_climate.htm	Edgar Link	pending
ea020161201ex-97_climate.htm	Edgar Link	pending
ea020161201ex19_climate.htm	Edgar Link	pending
ea020161201ex31-1_climate.htm	Edgar Link	pending
ea020161201ex31-2_climate.htm	Edgar Link	pending
ea020161201ex32-1_climate.htm	Edgar Link	pending
ea020161201ex32-2_climate.htm	Edgar Link	pending
ea020161201ex99-1_climate.htm	Edgar Link	pending
ea020161201ex99-2_climate.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
clcr-20231231_def.xml	Edgar Link	unprocessable
clcr-20231231_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
ea0201612-10k_climate_htm.xml	Edgar Link	completed
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
clcr-20231231_cal.xml	Edgar Link	unprocessable
clcr-20231231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CLRC
ClimateRock Stock $clrc

2023 Q4 Form 10-K Financial Statement

#000121390024023601 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRC ClimateRock Stock $clrc

2023 Q4 Form 10-K Financial Statement

#000121390024023601 Filed on March 18, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CLRC
ClimateRock Stock $clrc